Abbott: Fourth Quarter Earnings Overview

Abbott Laboratories Announces Fourth Quarter Financial Results

Abbott Laboratories, headquartered in Abbott Park, Illinois, reported a net profit of $1.78 billion for the fourth quarter.

The company’s earnings translated to $1.01 per share, while adjusted earnings—excluding amortization expenses—came in at $1.50 per share.

These adjusted earnings matched the consensus forecast from 10 analysts polled by Zacks Investment Research, who also anticipated $1.50 per share.

Abbott, known for its products in infant nutrition, pharmaceuticals, and medical devices, generated $11.46 billion in revenue during the quarter. This figure fell short of analyst expectations, as nine Zacks analysts had projected revenue of $11.78 billion.

Looking ahead to the first quarter ending in March, Abbott projects earnings per share to fall between $1.12 and $1.18.

For the full year, the company anticipates earnings per share to be in the range of $5.55 to $5.80.

Since the start of the year, Abbott’s stock price has declined by nearly 4%, whereas the S&P 500 index has remained relatively unchanged. Over the past year, Abbott shares have risen just over 3%.